chr20-34575211-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080476.5(PIGU):āc.1087A>Gā(p.Ile363Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,614,060 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_080476.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PIGU | NM_080476.5 | c.1087A>G | p.Ile363Val | missense_variant | 11/12 | ENST00000217446.8 | |
PIGU | XM_017027664.2 | c.943A>G | p.Ile315Val | missense_variant | 10/11 | ||
PIGU | XM_011528542.2 | c.439A>G | p.Ile147Val | missense_variant | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PIGU | ENST00000217446.8 | c.1087A>G | p.Ile363Val | missense_variant | 11/12 | 1 | NM_080476.5 | P1 | |
PIGU | ENST00000374820.6 | c.1027A>G | p.Ile343Val | missense_variant | 10/11 | 1 | |||
PIGU | ENST00000438215.1 | c.325A>G | p.Ile109Val | missense_variant | 5/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251406Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135882
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461862Hom.: 1 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727240
GnomAD4 genome AF: 0.000125 AC: 19AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74412
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2021 | The c.1087A>G (p.I363V) alteration is located in exon 11 (coding exon 11) of the PIGU gene. This alteration results from a A to G substitution at nucleotide position 1087, causing the isoleucine (I) at amino acid position 363 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with PIGU-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 363 of the PIGU protein (p.Ile363Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at